Department of Allergy and Clinical Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran AND Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Iran J Allergy Asthma Immunol. 2021 Feb 11;20(1):24-32. doi: 10.18502/ijaai.v20i1.5410.
Asthma, as the most common chronic disease in children, encompasses substantial health and socioeconomic burden worldwide. This study aimed to evaluate the prevalence, severity, and management of asthma in adolescents aged 13-14 years. This cross-sectional study, which was part of the Global Asthma Network (GAN) 2020 survey, was conducted in early 2020 in Yazd, Iran. A total of 48 schools in Yazd city were selected by cluster sampling. In this study, 5141 students, including 3069 (59.7%) females and 2072 (40.3%) males participated. Prevalence of ever and current wheezing was 19% and 9% respectively. The former was significantly higher in males than females (p<0.001). About 2% of the participants, which was 22.1% of students with current wheezing, had severe asthma. The prevalence of severe asthma was significantly higher in males (p=0.026). Our results showed that 4.8% of students had confirmed asthma by a doctor, significantly predominant in males (p<0.001). The prevalence of using inhaled medicines in the past 12 months was 3.8%, which was significantly higher in males than females (p<0.001). The prevalence of using short-acting β-agonists (SABA) and long-acting β-agonists (LABA) was 2.3% and 1.4% among the students, respectively, with a male predominance (p=0.019). About 1.2% and 0.8% of participants were using inhaled corticosteroids (ICS) and the combination of ICS and LABA, respectively, which was significantly higher in male participants (p<0.001). According to our findings and in comparison to the previous ISAAC study in Yazd, the prevalence of severe asthma has decreased which indicates better management of asthma during the past two decades.
哮喘是儿童最常见的慢性疾病,在全球范围内给儿童健康和社会经济带来了巨大负担。本研究旨在评估 13-14 岁青少年哮喘的患病率、严重程度和管理情况。这项横断面研究是全球哮喘网络(GAN)2020 年调查的一部分,于 2020 年初在伊朗亚兹德进行。亚兹德市共有 48 所学校通过聚类抽样入选。在这项研究中,共有 5141 名学生参与,其中 3069 名(59.7%)为女性,2072 名(40.3%)为男性。既往和现患喘息的患病率分别为 19%和 9%。前者在男性中显著高于女性(p<0.001)。约有 2%的参与者(即现患喘息者的 22.1%)患有严重哮喘。严重哮喘的患病率在男性中显著更高(p=0.026)。我们的结果表明,有 4.8%的学生经医生确诊患有哮喘,男性显著高于女性(p<0.001)。在过去 12 个月中使用吸入药物的患病率为 3.8%,男性显著高于女性(p<0.001)。过去 12 个月使用短效β-激动剂(SABA)和长效β-激动剂(LABA)的学生比例分别为 2.3%和 1.4%,男性占优势(p=0.019)。约有 1.2%和 0.8%的参与者分别使用吸入皮质类固醇(ICS)和 ICS 与 LABA 的联合制剂,男性参与者显著更高(p<0.001)。根据我们的发现,并与亚兹德之前的 ISAAC 研究相比,严重哮喘的患病率有所下降,这表明在过去二十年中,哮喘的管理得到了改善。